- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05503784
Study to Evaluate the Efficacy of Bite's Natural Deodorant
August 15, 2022 updated by: Kind Lab PBC.
This is an open-label observational single-arm clinical trial to study the efficacy of a commercial deodorant and its effect on odor, clothing (stains), and quality of life.
It is hypothesized that the deodorant marketed as Bite deodorant will mask bodily odor in participants, will not stain clothes, and improve the quality of life in trial participants.
Study Overview
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Santa Monica, California, United States, 90404
- Citruslabs
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
24 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Agree to refrain from the use of any other deodorant or antiperspirant other than Bite for the study period
- Must be in good health (does not report any medical conditions asked in the screening questionnaire)
- Must be willing to comply with the requirements of the protocol
- Must be willing to add the deodorant to their daily routine
- Is willing and able to share feedback
- Shower daily, and put deodorant on the first thing in the morning (before sweating)
- If used deodorants previously must be a natural version
Exclusion Criteria:
- Unwilling to follow the routine of the protocol
- Currently participating in another research study
- Severe chronic conditions including oncological conditions, psychiatric disease, or other
- Females that are pregnant, want to become pregnant for the duration of the study, or who are breastfeeding
- Presence of self-reported armpit sensitivity
- Known to have severe allergic reactions
- Have known allergies to the trial product ingredients
- Currently using an antiperspirant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Bite Deodorant
All 38 participants apply BITE deodorant daily for four weeks.
|
BITE natural Deodorant
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in underarm odor
Time Frame: 4 weeks
|
Survey-based assessment (0-5 scale) of changes in underarm odor
|
4 weeks
|
|
Changes in clothing staining
Time Frame: 4 weeks
|
survey-based assessment (0-5 scale) of changes in clothing staining
|
4 weeks
|
|
Changes in reported quality of life
Time Frame: 4 weeks
|
survey-based assessment (0-5 scale) of changes in reported quality of life
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 26, 2021
Primary Completion (Actual)
March 11, 2022
Study Completion (Actual)
March 11, 2022
Study Registration Dates
First Submitted
August 15, 2022
First Submitted That Met QC Criteria
August 15, 2022
First Posted (Actual)
August 17, 2022
Study Record Updates
Last Update Posted (Actual)
August 17, 2022
Last Update Submitted That Met QC Criteria
August 15, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 20227
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sweat
-
University of Arkansas, FayettevilleNot yet recruitingHeat Effect | Sweat Rate | Sweat Sodium Concentration
-
PepsiCo Global R&DRecruitingNormative Data for Sweating Rate, Sweat Sodium Concentration and Sweat Sodium Loss in Female AthleteSweat RateUnited States
-
Universidad Católica San Antonio de MurciaCompleted
-
University of Arkansas, FayettevilleCompletedSweat Sodium ConcentrationUnited States
-
San Diego State UniversityCompleted
-
PepsiCo Global R&DCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
USDA, Western Human Nutrition Research CenterUniversity of California, DavisCompletedStability & Variability of Lipid-derived Molecules in SweatUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedThe Sweat Alcohol Concentration
Clinical Trials on BITE Deodorant
-
KingdomCompleted
-
Mansoura UniversityUnknown
-
Dow University of Health SciencesActive, not recruitingSurgical Wound Infection | Surgical Wound Dehiscence | Wound Closure Techniques | Suture Techniques | Laparotomy/Standerds | Incisional Hernia/Prevention and ControlPakistan
-
Cairo UniversityCompleted
-
University of MichiganDelta Dental Fund of MichiganCompletedTooth Wear | Sleep BruxismUnited States
-
Eli Lilly and CompanyCompletedHealthy ParticipantsUnited States
-
University of ChicagoWithdrawnProstatectomyUnited States
-
University of CambridgeCompletedHereditary Diffuse Gastric CancerUnited Kingdom
-
Medical University of South CarolinaClemson UniversityCompleted
-
Pakistan Institute of Living and LearningActive, not recruitingBinge-Eating Disorder | Bulimia Nervosa | Eating DisordersPakistan